Source link : https://newshealth.biz/health-news/vte-trial-as-doacs-face-off-apixaban-confirmed-safer/
Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the randomized COBRRA trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/direct-oral-anticoagulants-face-vte-trial-apixaban-confirmed-2026a10007nu?src=rss Author : Publish date : 2026-03-12 12:36:00 Copyright for syndicated content belongs to the linked Source.
The post VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-12 12:36:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8